BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17681274)

  • 1. Cell death in leukemia: passenger protein regulation by topoisomerase inhibitors.
    Jahnke U; Higginbottom K; Newland AC; Cotter FE; Allen PD
    Biochem Biophys Res Commun; 2007 Oct; 361(4):928-33. PubMed ID: 17681274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl-expressing cells.
    Wolanin K; Magalska A; Mosieniak G; Klinger R; McKenna S; Vejda S; Sikora E; Piwocka K
    Mol Cancer Res; 2006 Jul; 4(7):457-69. PubMed ID: 16849521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis.
    Higginbottom K; Jahnke U; Newland AC; Cotter FE; Allen PD
    Apoptosis; 2007 Oct; 12(10):1847-55. PubMed ID: 17636382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of survivin and aurora B kinase sensitizes mesothelioma cells by enhancing mitotic arrests.
    Kim KW; Mutter RW; Willey CD; Subhawong TK; Shinohara ET; Albert JM; Ling G; Cao C; Gi YJ; Lu B
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1519-25. PubMed ID: 17394948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of mitotic cell death induced by chemotherapy-mediated G2 checkpoint abrogation.
    Vogel C; Hager C; Bastians H
    Cancer Res; 2007 Jan; 67(1):339-45. PubMed ID: 17210716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cells.
    Riordan FA; Bravery CA; Mengubas K; Ray N; Borthwick NJ; Akbar AN; Hart SM; Hoffbrand AV; Mehta AB; Wickremasinghe RG
    Oncogene; 1998 Mar; 16(12):1533-42. PubMed ID: 9569020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents.
    Stiewe T; Parssanedjad K; Esche H; Opalka B; Pützer BM
    Cancer Res; 2000 Jul; 60(14):3957-64. PubMed ID: 10919674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration-dependent variable effects of etoposide on the cell cycle of CML cells.
    Fukumi S; Horiguchi-Yamada J; Iwase S; Ohno T; Yamada H
    Anticancer Res; 2000; 20(5A):3105-10. PubMed ID: 11062729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EVI5 protein associates with the INCENP-aurora B kinase-survivin chromosomal passenger complex and is involved in the completion of cytokinesis.
    Faitar SL; Sossey-Alaoui K; Ranalli TA; Cowell JK
    Exp Cell Res; 2006 Jul; 312(12):2325-35. PubMed ID: 16764853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G2 arrest in response to topoisomerase II inhibitors: the role of p53.
    Clifford B; Beljin M; Stark GR; Taylor WR
    Cancer Res; 2003 Jul; 63(14):4074-81. PubMed ID: 12874009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early caspase activation in leukemic cells subject to etoposide-induced G2-M arrest: evidence of commitment to apoptosis rather than mitotic cell death.
    Sleiman RJ; Stewart BW
    Clin Cancer Res; 2000 Sep; 6(9):3756-65. PubMed ID: 10999770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of mitochondrial membrane potential and caspase activation enhance apoptosis in irradiated K562 cells treated with herbimycin A.
    Jo WS; Jeong MH; Jin YH; Jang JY; Nam BH; Son SH; Choi SS; Yoo YH; Kang CD; Lee JD; Jeong SJ
    Int J Radiat Biol; 2005 Jul; 81(7):531-43. PubMed ID: 16263657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line.
    Morotti A; Cilloni D; Pautasso M; Messa F; Arruga F; Defilippi I; Carturan S; Catalano R; Rosso V; Chiarenza A; Taulli R; Bracco E; Rege-Cambrin G; Gottardi E; Saglio G
    Am J Hematol; 2006 Dec; 81(12):938-45. PubMed ID: 16960866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular localization and nucleocytoplasmic transport of the chromosomal passenger proteins before nuclear envelope breakdown.
    Rodriguez JA; Lens SM; Span SW; Vader G; Medema RH; Kruyt FA; Giaccone G
    Oncogene; 2006 Aug; 25(35):4867-79. PubMed ID: 16547492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin dynamics increases at centromeres during G2/M phase transition and is regulated by microtubule-attachment and Aurora B kinase activity.
    Beardmore VA; Ahonen LJ; Gorbsky GJ; Kallio MJ
    J Cell Sci; 2004 Aug; 117(Pt 18):4033-42. PubMed ID: 15280424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The modulation of radiation-induced cell death by genistein in K562 cells: activation of thymidine kinase 1.
    Jeong MH; Jin YH; Kang EY; Jo WS; Park HT; Lee JD; Yoo YJ; Jeong SJ
    Cell Res; 2004 Aug; 14(4):295-302. PubMed ID: 15353126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block.
    Nishii K; Kabarowski JH; Gibbons DL; Griffiths SD; Titley I; Wiedemann LM; Greaves MF
    Oncogene; 1996 Nov; 13(10):2225-34. PubMed ID: 8950990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of DNA topoisomerase IIalpha leads to prolonged cell cycle transit in G2 and early M phases and increased survival to microtubule-interacting agents.
    Skladanowski A; Côme MG; Sabisz M; Escargueil AE; Larsen AK
    Mol Pharmacol; 2005 Sep; 68(3):625-34. PubMed ID: 15942022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
    Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the apoptotic actions of etoposide are independent of c-Jun/activating protein-1-mediated transregulation.
    Jarvis WD; Johnson CR; Fornari FA; Park JS; Dent P; Grant S
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1384-92. PubMed ID: 10454518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.